Metal chelators for use in the treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4745 (2006.01) A61K 31/47 (2006.01) A61P 25/28 (2006.01) A61K 31/27 (2006.01) A61K 31/395 (2006.01) A61K 31/405 (2006.01)

Patent

CA 2323458

The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions and compositions for treatment of conditions caused by amyloidosis, A.beta.-mediated formation of ROS, or both, such as Alzheimer's disease, are disclosed.

L'invention concerne l'identification d'agents pharmacologiques destinés à être utilisés pour traiter la maladie d'Alzheimer ainsi que les troubles pathologiques liés à celle-ci. L'invention concerne également des compositions permettant de traiter les dysfonctionnements provoqués par l'amylose, par la formation de ROS à médiation A beta , ou par les deux, par exemple la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Metal chelators for use in the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metal chelators for use in the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal chelators for use in the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1364661

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.